Healthcare101

Discover the top 25 companies transforming the injection pen market, including Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and other industry leaders. Backed by a market projected to grow from $47.0B to $74.1B by 2030 at a CAGR of 7.9%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights. Download PDF Brochure: “ Click Here ” Spotlights on the Industry’s Top Injection Pen Companies Novo Nordisk A/S Novo Nordisk is a global healthcare leader specializing in diabetes care and other serious chronic diseases. The company is a pioneer in the injection pen market, offering an extensive portfolio of delivery systems including the FlexPen, FlexTouch, and the smart NovoPen 6 and NovoPen Echo Plus. Their devices are designed to enhance patient adherence through features like low injection force, audible dose confirmation, and digital dose memory, maintaini...

  The global Radiation Detection, Monitoring & Safety Market is poised for substantial growth over the next several years, driven by increasing nuclear energy investments, expanding use of medical imaging technologies, stricter radiation safety regulations, and growing security concerns worldwide. According to MarketsandMarkets™, the market is projected to grow from approximately USD 3.80 billion in 2026 to USD 5.68 billion by 2031, registering a CAGR of 8.4% during the forecast period. As industries increasingly rely on radiation-based technologies and governments strengthen safety standards, the demand for advanced radiation detection, monitoring, and protection solutions continues to accelerate across healthcare, nuclear power, defense, industrial manufacturing, and environmental monitoring sectors. Download PDF Brochure Growing Importance of Radiation Safety Across Industries Radiation plays a vital role in several critical industries, particularly healthcare, energy gene...

  The global Drug Screening Industry is undergoing a major transformation as governments, healthcare systems, employers, and law enforcement agencies intensify efforts to address rising substance abuse and workplace safety concerns. According to the latest analysis, the global drug screening market is projected to grow from USD 10.36 billion in 2025 to USD 21.29 billion by 2030, registering a robust CAGR of 15.5% during the forecast period. The increasing prevalence of polysubstance abuse, growing demand for rapid and accurate testing technologies, stricter workplace compliance regulations, and the expansion of roadside and forensic testing programs are collectively driving market growth worldwide. Download PDF Brochure Rising Polysubstance Use Driving Demand for Advanced Drug Testing One of the primary factors accelerating the growth of the drug screening market is the global rise in polysubstance use. Drug consumption patterns have evolved significantly over the last decade, wi...